PHORBOL 12-MYRISTATE 13-ACETATE - Sigma … of interleukin-2 (IL-2). Phorbol 12-myristate...

1
PHORBOL 12-MYRISTATE 13-ACETATE (4β,9α,12β,13α,20-pentahydroxytiglia-1,6-dien-3-one 12β-myristate 13-acetate; 12-O-tetradecanoylphorbol 13-acetate) Molecular Biology Reagent Product No. P 1585 Product Description T-cell activation is normally triggered by the interaction of a cell surface receptor to its specific ligand molecule. This binding event triggers the rapid hydrolysis of inositol phospholipids to diacylglycerol and inositol phosphates by phospholipase C (PLC). Diacylglycerol is an allosteric activator of protein kinase C (PKC) activation and inositol phosphates, which trigger Ca ++ release and mobilization, resulting in a cascade of additional cellular responses mediating T-cell activation. One of these cellular responses is the production and secretion of interleukin-2 (IL-2). Phorbol 12-myristate 13-acetate, which has a structure analogous to diacylglycerol, can also activate PKC. Jurkat cells are a leukemic T-cell line known to produce IL-2. Under normal growth conditions, little to no IL-2 is produced in Jurkat cells. PMA, through its activation of PKC, can activate T-cells and stimulate low-level production of IL-2. When Jurkat cells are stimulated by PMA and a co-stimulator, such as PHA, IL-2 production is strongly enhanced 2 . Phytohemagglutinin can trigger a low level of T-cell activation and IL-2 production by binding non-specifically to the cell surface receptor complex. The combination of PMA and PHA results in greatly increased IL-2 production and secretion. Storage/Stability Store below 0 °C All stock solutions should be stored at –20 °C Product Profile Tested using Jurkat cells grown in the presence of 1 µg/ml phytohemagglutinin (PHA) and 50 ng/ml phorbol 12-myristate 13-acetate. IL-2 production was pg/10 6 Jurkat cells. Soluble in ethanol and DMSO. Suitability Assay 2.5 ml of Jurkat cells (1 x 10 6 cells/ ml) and 2.5 ml of fresh media (RPMI 1640 + 10% fetal calf serum containing 10 ml/l penicillin-streptomycin) were added to 25 cm 2 culture bottles. The following additions were made in duplicate. a. Control - no additions b. 1 µg/ml PHA Control - add 10 µl PHA stock solution (0.5 mg/ml PHA in filter-sterilized PBS) c. 1 µg/ml PHA + 50 ng/ml PMA – 10 µl PHA stock solution + 2.5 µl PMA stock solution (100 µg/ml PMA in DMSO) The bottles were incubated at 37 °C for 24 hours. After centrifugation, the clarified broth was tested for IL-2 production using a Human Interleukin-2 ELISA test kit (Sigma Stock No. CKH-102). The PMA + PHA test cultures yielded a level of production of IL-2 pg IL-2/10 6 Jurkat cells. The PHA control culture yielded <3,000 pg IL-2/10 6 Jurkat cells. The control with no addition was <50 pg IL-2/10 6 Jurkat cells. References 1. Weiss, A., et al., J. Immunol., 133, 123 (1984) 2. Manger, B., et al., J. Clin. Invest. 77, 1501 (1986) JWM/2002 Sigma brand products are sold through Sigma-Aldrich, Inc. Sigma-Aldrich, Inc. warrants that its products conform to the information contained in this and other Sigma-Aldrich publications. Purchaser must determine the suitability of the product(s) for their particular use. Additional terms and conditions may apply. Please see reverse side of the invoice or packing slip.

Transcript of PHORBOL 12-MYRISTATE 13-ACETATE - Sigma … of interleukin-2 (IL-2). Phorbol 12-myristate...

Page 1: PHORBOL 12-MYRISTATE 13-ACETATE - Sigma … of interleukin-2 (IL-2). Phorbol 12-myristate 13-acetate, which has a structure analogous to diacylglycerol, can also activate PKC.

PHORBOL 12-MYRISTATE 13-ACETATE(4β,9α,12β,13α,20-pentahydroxytiglia-1,6-dien-3-one12β-myristate 13-acetate; 12-O-tetradecanoylphorbol 13-acetate)Molecular Biology Reagent

Product No. P 1585

Product DescriptionT-cell activation is normally triggered by the interactionof a cell surface receptor to its specific ligand molecule. This binding event triggers the rapid hydrolysis ofinositol phospholipids to diacylglycerol and inositolphosphates by phospholipase C (PLC). Diacylglycerolis an allosteric activator of protein kinase C (PKC)activation and inositol phosphates, which trigger Ca++

release and mobilization, resulting in a cascade ofadditional cellular responses mediating T-cell activation. One of these cellular responses is the production andsecretion of interleukin-2 (IL-2). Phorbol 12-myristate13-acetate, which has a structure analogous todiacylglycerol, can also activate PKC.

Jurkat cells are a leukemic T-cell line known to produceIL-2. Under normal growth conditions, little to no IL-2 isproduced in Jurkat cells. PMA, through its activation ofPKC, can activate T-cells and stimulate low-levelproduction of IL-2. When Jurkat cells are stimulated byPMA and a co-stimulator, such as PHA, IL-2 productionis strongly enhanced2. Phytohemagglutinin can triggera low level of T-cell activation and IL-2 production bybinding non-specifically to the cell surface receptorcomplex. The combination of PMA and PHA results ingreatly increased IL-2 production and secretion.

Storage/StabilityStore below 0 °CAll stock solutions should be stored at –20 °C

Product ProfileTested using Jurkat cells grown in the presence of1 µg/ml phytohemagglutinin (PHA) and 50 ng/ml phorbol12-myristate 13-acetate. IL-2 production was������� pg/106 Jurkat cells.Soluble in ethanol and DMSO.

Suitability Assay2.5 ml of Jurkat cells (1 x 106 cells/ ml) and 2.5 ml offresh media (RPMI 1640 + 10% fetal calf serumcontaining 10 ml/l penicillin-streptomycin) were added to25 cm2 culture bottles. The following additions weremade in duplicate.

a. Control - no additionsb. 1 µg/ml PHA Control - add 10 µl PHA stock solution

(0.5 mg/ml PHA in filter-sterilized PBS)c. 1 µg/ml PHA + 50 ng/ml PMA – 10 µl PHA stock

solution + 2.5 µl PMA stock solution (100 µg/mlPMA in DMSO)

The bottles were incubated at 37 °C for 24 hours. Aftercentrifugation, the clarified broth was tested for IL-2production using a Human Interleukin-2 ELISA test kit(Sigma Stock No. CKH-102). The PMA + PHA testcultures yielded a level of production of IL-2 ������� pgIL-2/106 Jurkat cells. The PHA control culture yielded<3,000 pg IL-2/106 Jurkat cells. The control with noaddition was <50 pg IL-2/106 Jurkat cells.

References1. Weiss, A., et al., J. Immunol., 133, 123 (1984)2. Manger, B., et al., J. Clin. Invest. 77, 1501 (1986)

JWM/2002

Sigma brand products are sold through Sigma-Aldrich, Inc.Sigma-Aldrich, Inc. warrants that its products conform to the information contained in this and other Sigma-Aldrich publications.

Purchaser must determine the suitability of the product(s) for their particular use. Additional terms and conditions may apply.Please see reverse side of the invoice or packing slip.